Header Logo

DANIEL AYANGA

Concepts (11)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Opiate Substitution Treatment
1
2016
22
0.550
 Why?
Adrenergic alpha-2 Receptor Agonists
1
2016
24
0.540
 Why?
Narcotic Antagonists
1
2016
104
0.520
 Why?
Buprenorphine
1
2016
92
0.510
 Why?
Opioid-Related Disorders
1
2016
258
0.430
 Why?
Clonidine
1
2016
35
0.140
 Why?
Naltrexone
1
2016
69
0.130
 Why?
Methadone
1
2016
124
0.130
 Why?
Combined Modality Therapy
1
2016
1240
0.110
 Why?
Treatment Outcome
1
2016
12102
0.050
 Why?
Humans
1
2016
123190
0.010
 Why?
AYANGA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (11)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_